Immunobiology and pathogenesis of hepatitis B virus infection
Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host dete...
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Immunology Jg. 22; H. 1; S. 19 - 32 |
|---|---|
| Hauptverfasser: | , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
Nature Publishing Group UK
01.01.2022
Nature Publishing Group |
| Schlagworte: | |
| ISSN: | 1474-1733, 1474-1741, 1474-1741 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8
+
T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver — and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis — profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection.
In this Review, Iannacone and Guidotti discuss the immunobiology and pathogenesis of hepatitis B virus (HBV) infection, with a particular focus on the role of CD8
+
T cells, and examine recent breakthroughs that challenge current dogmas. |
|---|---|
| AbstractList | Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8
+
T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver — and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis — profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection.
In this Review, Iannacone and Guidotti discuss the immunobiology and pathogenesis of hepatitis B virus (HBV) infection, with a particular focus on the role of CD8
+
T cells, and examine recent breakthroughs that challenge current dogmas. Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8 T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver - and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis - profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection. Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8+ T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver - and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis - profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection.Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8+ T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver - and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis - profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection. Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8+ T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver — and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis — profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection.In this Review, Iannacone and Guidotti discuss the immunobiology and pathogenesis of hepatitis B virus (HBV) infection, with a particular focus on the role of CD8+ T cells, and examine recent breakthroughs that challenge current dogmas. |
| Author | Iannacone, Matteo Guidotti, Luca G. |
| Author_xml | – sequence: 1 givenname: Matteo orcidid: 0000-0002-9370-2671 surname: Iannacone fullname: Iannacone, Matteo email: iannacone.matteo@hsr.it organization: Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute – sequence: 2 givenname: Luca G. orcidid: 0000-0002-0205-2678 surname: Guidotti fullname: Guidotti, Luca G. email: guidotti.luca@hsr.it organization: Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34002067$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kTtPwzAUhS1URKHwBxhQJBaWgJ9xMjBAxUtCYoHZcly7dZXYxU6Q-u9xCQWpQ6fre_2dq2OfEzBy3mkAzhG8RpCUN5EixnkOMcohZLTK6QE4RpTTHHGKRn9nQsbgJMYlhKhIN0dgTCiEGBb8GNy-tG3vfG194-frTLpZtpLdws-109HGzJtsodPEdqm5z75s6GNmndGqs96dgkMjm6jPfusEfDw-vE-f89e3p5fp3WuuKEVdrjhEmpVY1UwrU0hYUmMQIYbxWVUXlFCiiqrYOGJMGl4ZjmuFlDFccigrMgFXw95V8J-9jp1obVS6aaTTvo8CM1yWGFYcJvRyB136PrjkTuACFZQzTHmiLn6pvm71TKyCbWVYi-3HJKAcABV8jEEboWwnN2_ugrSNQFBsMhBDBiJlIH4yEDRJ8Y50u32viAyimGA31-Hf9h7VNwj2lz4 |
| CitedBy_id | crossref_primary_10_2139_ssrn_5400029 crossref_primary_10_1016_j_jmii_2025_06_004 crossref_primary_10_1016_j_virs_2023_10_007 crossref_primary_10_3389_fmed_2022_882878 crossref_primary_10_1016_j_ejps_2024_106834 crossref_primary_10_1016_j_micpath_2022_105648 crossref_primary_10_1002_jmv_70398 crossref_primary_10_1002_ctm2_1731 crossref_primary_10_3350_cmh_2022_0420 crossref_primary_10_3389_fcimb_2023_1248782 crossref_primary_10_3390_v13091691 crossref_primary_10_1016_j_lanwpc_2022_100638 crossref_primary_10_1126_sciimmunol_abi6112 crossref_primary_10_12968_hmed_2024_0850 crossref_primary_10_3892_mco_2025_2871 crossref_primary_10_1080_14737140_2023_2203387 crossref_primary_10_1038_s41392_024_02072_z crossref_primary_10_1038_s41598_025_93778_9 crossref_primary_10_1097_HC9_0000000000000111 crossref_primary_10_1084_jem_20242078 crossref_primary_10_1016_j_coviro_2022_101205 crossref_primary_10_1038_s41467_022_34867_5 crossref_primary_10_1016_j_cell_2024_05_038 crossref_primary_10_1016_j_cld_2023_05_001 crossref_primary_10_1097_HEP_0000000000000386 crossref_primary_10_1136_gutjnl_2024_332105 crossref_primary_10_1155_2023_1914036 crossref_primary_10_1002_jmv_70287 crossref_primary_10_1002_jmv_28749 crossref_primary_10_1038_s41467_025_60894_z crossref_primary_10_1002_jmv_27779 crossref_primary_10_3389_fimmu_2025_1611976 crossref_primary_10_3390_vaccines12040396 crossref_primary_10_38053_acmj_1679398 crossref_primary_10_1128_spectrum_01328_21 crossref_primary_10_1080_14656566_2022_2144219 crossref_primary_10_1128_jvi_01090_23 crossref_primary_10_2147_JIR_S477202 crossref_primary_10_1016_j_fitote_2025_106737 crossref_primary_10_3389_fcimb_2022_1062553 crossref_primary_10_3389_fmicb_2023_1213145 crossref_primary_10_1111_1348_0421_12964 crossref_primary_10_1186_s12879_024_10408_x crossref_primary_10_3390_ijms242015460 crossref_primary_10_1016_j_bmcl_2024_130054 crossref_primary_10_1093_jimmun_vkaf095 crossref_primary_10_1111_cpr_13450 crossref_primary_10_1111_aji_13610 crossref_primary_10_3390_pathogens14010008 crossref_primary_10_3389_fimmu_2025_1553411 crossref_primary_10_1126_scitranslmed_adv3678 crossref_primary_10_1136_egastro_2024_100067 crossref_primary_10_3389_fmed_2022_1002260 crossref_primary_10_1016_j_jhep_2024_02_017 crossref_primary_10_1371_journal_pone_0305862 crossref_primary_10_1371_journal_ppat_1013390 crossref_primary_10_3390_v15122367 crossref_primary_10_1111_jvh_13958 crossref_primary_10_1186_s12967_024_05206_7 crossref_primary_10_1080_17460794_2024_2415216 crossref_primary_10_1097_HC9_0000000000000331 crossref_primary_10_1080_22221751_2022_2077128 crossref_primary_10_1016_j_jhep_2025_08_008 crossref_primary_10_3389_fimmu_2023_1147379 crossref_primary_10_1038_s41590_025_02199_3 crossref_primary_10_1128_spectrum_03447_23 crossref_primary_10_3389_fimmu_2022_1075916 crossref_primary_10_1016_j_isci_2023_108723 crossref_primary_10_1007_s12032_025_02674_9 crossref_primary_10_3390_jcm12052000 crossref_primary_10_1515_hsz_2022_0345 crossref_primary_10_3389_fimmu_2022_904342 crossref_primary_10_3389_fimmu_2023_1141956 crossref_primary_10_3389_fimmu_2022_853346 crossref_primary_10_3390_biomedicines12030515 crossref_primary_10_3389_fimmu_2022_1034968 crossref_primary_10_1111_jvh_13962 crossref_primary_10_1016_j_antiviral_2022_105385 crossref_primary_10_1016_j_jhep_2025_08_016 crossref_primary_10_1111_jvh_13840 crossref_primary_10_1002_wsbm_1640 crossref_primary_10_1039_D2BM00407K crossref_primary_10_3389_fphy_2021_731972 crossref_primary_10_3390_bios11110442 crossref_primary_10_1016_j_genrep_2023_101747 crossref_primary_10_3389_fimmu_2022_993246 crossref_primary_10_3389_fimmu_2024_1427519 crossref_primary_10_1016_j_ygeno_2025_111079 crossref_primary_10_1007_s00432_023_05291_z crossref_primary_10_3390_v14112490 crossref_primary_10_3390_ijms26167761 crossref_primary_10_3390_v16050707 crossref_primary_10_3390_diseases11030094 crossref_primary_10_3390_ijms232415973 crossref_primary_10_1097_ID9_0000000000000174 crossref_primary_10_3389_fimmu_2023_1142319 crossref_primary_10_3390_biomedicines9111577 crossref_primary_10_3892_mmr_2023_12950 crossref_primary_10_3390_biom13081208 crossref_primary_10_1007_s10238_024_01537_3 crossref_primary_10_1016_j_jhep_2023_09_019 crossref_primary_10_1016_j_celrep_2025_115457 crossref_primary_10_1002_INMD_20240134 crossref_primary_10_3389_fcimb_2023_1126311 crossref_primary_10_3390_pathogens13090766 crossref_primary_10_1016_j_ejmech_2022_114833 crossref_primary_10_1016_j_heliyon_2024_e31412 crossref_primary_10_3389_fgene_2025_1619911 crossref_primary_10_3389_fonc_2023_1103512 crossref_primary_10_1007_s00705_024_06133_0 crossref_primary_10_1089_vim_2022_0135 crossref_primary_10_1097_COC_0000000000001133 crossref_primary_10_1186_s12985_025_02907_3 crossref_primary_10_1038_s41419_022_05444_x crossref_primary_10_1177_17588359241289202 crossref_primary_10_2147_DDDT_S480151 crossref_primary_10_1016_j_antiviral_2024_106017 crossref_primary_10_3390_pharmaceutics14071439 crossref_primary_10_3892_wasj_2025_351 crossref_primary_10_1111_apt_70213 crossref_primary_10_1128_spectrum_00909_24 crossref_primary_10_1002_jcla_24860 crossref_primary_10_1038_s41467_025_59985_8 crossref_primary_10_1002_mco2_499 crossref_primary_10_1186_s12964_023_01091_7 crossref_primary_10_1002_jmv_28670 crossref_primary_10_1007_s00109_023_02405_5 crossref_primary_10_1002_hep_32445 crossref_primary_10_1007_s10529_023_03359_x crossref_primary_10_2147_JIR_S355301 crossref_primary_10_3389_fimmu_2022_944097 crossref_primary_10_1038_s41598_024_85012_9 crossref_primary_10_1186_s12865_022_00537_w crossref_primary_10_1002_smll_202401499 crossref_primary_10_1016_j_microb_2024_100193 crossref_primary_10_1186_s12876_024_03270_3 crossref_primary_10_3390_biomedicines10092210 crossref_primary_10_5501_wjv_v12_i5_296 crossref_primary_10_1186_s12935_024_03521_z crossref_primary_10_1016_S0140_6736_22_01468_4 crossref_primary_10_1016_j_jhep_2024_06_033 crossref_primary_10_3390_biomedicines10010196 crossref_primary_10_2147_JIR_S471675 crossref_primary_10_1371_journal_ppat_1012815 crossref_primary_10_1016_S2468_1253_25_00053_6 crossref_primary_10_1016_j_virol_2024_110199 crossref_primary_10_3389_fimmu_2024_1357496 crossref_primary_10_1016_j_jlr_2025_100866 crossref_primary_10_4254_wjh_v16_i12_1515 crossref_primary_10_37349_edd_2025_100565 crossref_primary_10_1002_jmv_29659 crossref_primary_10_3389_fpubh_2025_1445543 crossref_primary_10_1038_s41598_022_09312_8 crossref_primary_10_1016_j_imbio_2025_152913 crossref_primary_10_3390_molecules29204872 crossref_primary_10_3389_fimmu_2023_1106700 crossref_primary_10_3390_v16121960 crossref_primary_10_1016_j_antiviral_2023_105643 crossref_primary_10_1038_s41598_024_70924_3 crossref_primary_10_2147_JIR_S347702 crossref_primary_10_3389_fcimb_2024_1332666 crossref_primary_10_1016_j_meegid_2024_105618 crossref_primary_10_3389_fonc_2024_1407434 crossref_primary_10_1002_jmv_28578 crossref_primary_10_1097_MJT_0000000000001651 crossref_primary_10_1051_parasite_2025011 crossref_primary_10_3350_cmh_2024_0837 crossref_primary_10_1021_acs_analchem_5c02141 crossref_primary_10_3390_vaccines10050746 crossref_primary_10_1016_j_bioelechem_2025_108901 crossref_primary_10_1016_j_bios_2025_117579 crossref_primary_10_1159_000539994 crossref_primary_10_1016_j_immuni_2024_11_021 crossref_primary_10_1099_jgv_0_001978 crossref_primary_10_3390_vaccines9111333 crossref_primary_10_1016_j_coi_2022_102207 crossref_primary_10_1186_s10020_025_01105_9 crossref_primary_10_1016_S1875_5364_23_60505_9 crossref_primary_10_3390_v14071543 crossref_primary_10_3748_wjg_v28_i27_3282 crossref_primary_10_1016_j_antiviral_2023_105592 crossref_primary_10_1186_s43556_022_00088_x crossref_primary_10_3389_fmed_2022_814423 crossref_primary_10_3389_fpubh_2024_1398254 crossref_primary_10_3390_pathogens11101116 crossref_primary_10_1007_s00018_024_05404_y crossref_primary_10_1038_s41416_022_02115_8 crossref_primary_10_3389_fmicb_2022_887408 crossref_primary_10_3389_fonc_2023_1230164 crossref_primary_10_3390_medicina59050923 crossref_primary_10_3748_wjg_v30_i10_1295 crossref_primary_10_1016_j_virs_2023_12_005 crossref_primary_10_1038_s41586_024_07630_7 crossref_primary_10_1080_17474124_2025_2477256 crossref_primary_10_1007_s00203_023_03602_z crossref_primary_10_1002_iid3_70118 crossref_primary_10_1016_j_nut_2024_112447 crossref_primary_10_1172_JCI165033 crossref_primary_10_1016_j_clim_2023_109320 crossref_primary_10_1080_10255842_2024_2427117 crossref_primary_10_1126_scitranslmed_adi1572 crossref_primary_10_4254_wjh_v17_i1_98658 crossref_primary_10_1515_rnam_2023_0008 crossref_primary_10_3389_fonc_2023_1185142 crossref_primary_10_1016_j_bbcan_2024_189156 crossref_primary_10_3389_fcimb_2023_1173505 crossref_primary_10_1002_jmv_29569 crossref_primary_10_3390_genes13111941 crossref_primary_10_1016_j_virol_2025_110527 crossref_primary_10_1186_s13020_024_00888_z crossref_primary_10_3389_fonc_2022_970613 crossref_primary_10_3390_vaccines11030681 crossref_primary_10_1038_d41586_022_00813_0 crossref_primary_10_3389_fmicb_2023_1172574 crossref_primary_10_1080_17455030_2023_2178827 crossref_primary_10_1159_000542946 crossref_primary_10_3390_cancers16081606 crossref_primary_10_3390_bios15040231 crossref_primary_10_1016_j_antiviral_2024_105975 crossref_primary_10_1172_jci_insight_190740 crossref_primary_10_1016_j_jsps_2024_102126 crossref_primary_10_1007_s11033_023_08450_0 crossref_primary_10_1080_22221751_2022_2100831 crossref_primary_10_1111_apt_16850 crossref_primary_10_1016_j_physleta_2024_129985 crossref_primary_10_1056_NEJMra2211764 crossref_primary_10_3350_cmh_2023_0412 crossref_primary_10_3389_fcimb_2023_1140126 crossref_primary_10_1016_j_livres_2025_09_002 crossref_primary_10_1111_apt_17382 crossref_primary_10_1016_j_imbio_2025_153093 crossref_primary_10_3390_ph15121542 crossref_primary_10_3389_fimmu_2023_1166171 crossref_primary_10_1080_17474124_2023_2268503 crossref_primary_10_1016_j_virusres_2024_199316 crossref_primary_10_3748_wjg_v30_i44_4725 crossref_primary_10_3389_fimmu_2022_884290 crossref_primary_10_1007_s11033_025_10278_9 crossref_primary_10_1111_jcmm_18440 crossref_primary_10_3390_ijms24087651 crossref_primary_10_1016_j_arabjc_2023_105155 crossref_primary_10_1002_jmv_28376 crossref_primary_10_1007_s12026_025_09656_z crossref_primary_10_1080_0886022X_2024_2417737 crossref_primary_10_1016_j_antiviral_2023_105680 crossref_primary_10_1038_s41467_023_43078_5 crossref_primary_10_3389_fmolb_2022_879817 crossref_primary_10_1146_annurev_immunol_090122_041354 crossref_primary_10_3390_v16040574 crossref_primary_10_1016_j_ygeno_2023_110642 crossref_primary_10_1016_j_aca_2024_342702 crossref_primary_10_1016_j_ymthe_2025_06_027 crossref_primary_10_1007_s12072_023_10490_4 crossref_primary_10_3389_fgene_2023_1265268 crossref_primary_10_1007_s10238_022_00792_6 crossref_primary_10_1016_j_bmcl_2022_128904 crossref_primary_10_1002_eji_202451046 crossref_primary_10_1016_j_virs_2024_03_003 crossref_primary_10_1007_s11262_024_02105_3 crossref_primary_10_1136_bmj_2024_079579 crossref_primary_10_3389_fimmu_2022_805018 crossref_primary_10_1089_vim_2024_0006 crossref_primary_10_3390_cancers16071370 crossref_primary_10_3390_v16020167 crossref_primary_10_1016_j_cvsm_2025_03_006 crossref_primary_10_3390_microorganisms13081787 crossref_primary_10_12677_TCM_2023_1212517 crossref_primary_10_1002_jmv_70360 crossref_primary_10_1177_03000605221104760 crossref_primary_10_3390_gidisord6010005 crossref_primary_10_3389_fmed_2022_821710 crossref_primary_10_7717_peerj_14454 crossref_primary_10_1002_iid3_1182 crossref_primary_10_1038_s41598_023_48766_2 crossref_primary_10_1016_j_prp_2023_154729 crossref_primary_10_1002_jmv_29241 crossref_primary_10_1089_vim_2022_0183 crossref_primary_10_1038_s41575_024_01015_x crossref_primary_10_3389_fimmu_2022_1096402 crossref_primary_10_22207_JPAM_16_3_02 crossref_primary_10_1016_j_cyto_2023_156442 crossref_primary_10_1080_15583724_2023_2281462 crossref_primary_10_1136_egastro_2023_100021 crossref_primary_10_3390_microorganisms9081787 crossref_primary_10_3390_molecules26247420 crossref_primary_10_1002_ctm2_70172 crossref_primary_10_1002_adhm_202303897 crossref_primary_10_1186_s12876_025_03999_5 crossref_primary_10_3390_biomedicines10061224 crossref_primary_10_1016_j_antiviral_2024_105896 crossref_primary_10_3389_fimmu_2025_1567459 crossref_primary_10_12688_openreseurope_20378_1 crossref_primary_10_2478_amma_2025_0036 crossref_primary_10_1002_smll_202308646 crossref_primary_10_3389_fphar_2021_756975 crossref_primary_10_1016_j_bbcan_2022_188799 crossref_primary_10_1186_s12876_025_04126_0 crossref_primary_10_3389_fgene_2021_654517 crossref_primary_10_1080_00365521_2023_2254438 crossref_primary_10_3390_cells13010071 crossref_primary_10_1155_2022_7881478 crossref_primary_10_1002_med_21940 crossref_primary_10_1097_HEP_0000000000001371 crossref_primary_10_1016_j_micpath_2025_107938 crossref_primary_10_4254_wjh_v17_i4_105797 crossref_primary_10_1038_s41577_024_01097_3 crossref_primary_10_1038_s41575_023_00760_9 crossref_primary_10_1016_j_jff_2025_107019 |
| Cites_doi | 10.1016/S2468-1253(19)30119-0 10.1073/pnas.91.9.3764 10.1172/JCI116950 10.1002/hep.1840210410 10.1038/s41573-019-0037-0 10.1073/pnas.0708968104 10.1016/j.coviro.2018.01.008 10.1084/jem.20162115 10.1073/pnas.0308478100 10.4049/jimmunol.161.9.4520 10.7554/eLife.00049 10.1038/nm1096-1104 10.1073/pnas.88.10.4186 10.1172/JCI107284 10.1002/hep.1840050427 10.1084/jem.191.8.1269 10.1038/cti.2016.53 10.1084/jem.20011723 10.1016/j.jhep.2016.01.026 10.1053/j.gastro.2016.07.012 10.1128/CVI.00298-07 10.1111/jvh.12380 10.1073/pnas.1209182109 10.1073/pnas.92.26.12398 10.1172/JCI200421087 10.1016/S1074-7613(00)80295-2 10.1073/pnas.0401771101 10.1053/jhep.2002.31867 10.1038/369407a0 10.1038/s41598-018-23343-0 10.1126/science.284.5415.825 10.1073/pnas.0406282101 10.1172/JCI121960 10.1038/nm.4275 10.1152/physrev.00027.2008 10.1038/cmi.2015.25 10.1002/hep.26125 10.1016/j.jhep.2015.05.033 10.1073/pnas.1635109100 10.1016/j.jhep.2019.07.015 10.1084/jem.194.12.1755 10.1136/gutjnl-2014-308964 10.1245/s10434-016-5520-9 10.1146/annurev.pathol.1.110304.100230 10.1016/j.antiviral.2020.104816 10.1002/hep.22962 10.1172/JCI68182 10.7554/eLife.26738 10.1126/scitranslmed.aan0241 10.4049/jimmunol.152.7.3245 10.4049/jimmunol.158.12.5692 10.1016/0016-5085(90)90028-Y 10.1128/JVI.76.7.3570-3574.2002 10.1038/s41426-018-0034-0 10.1016/j.jhep.2016.02.021 10.1016/j.immuni.2005.05.005 10.1128/jvi.67.12.7032-7040.1993 10.1056/NEJMoa1912035 10.1038/cmi.2014.78 10.1016/j.jhep.2017.04.020 10.1371/journal.ppat.1002061 10.3390/cancers12113215 10.1128/JVI.78.11.5707-5719.2004 10.1128/JVI.79.11.7269-7272.2005 10.1146/annurev-micro-092611-150203 10.1016/j.ccell.2018.03.002 10.3390/v9030056 10.1053/j.gastro.2018.01.034 10.1172/JCI24282 10.1053/j.gastro.2020.04.019 10.1128/JVI.79.5.3016-3027.2005 10.1172/JCI67008 10.1053/j.gastro.2015.09.026 10.1084/jem.20200298 10.1111/j.1440-1746.2008.05348.x 10.1006/viro.1996.0661 10.1038/cmi.2014.79 10.1128/JVI.76.17.8609-8620.2002 10.1002/hep.28650 10.1136/gutjnl-2018-316641 10.1016/j.phrs.2019.104585 10.1002/cld.904 10.1038/s41586-019-1620-6 10.1172/JCI92812 10.1053/j.gastro.2020.09.007 10.1016/S0140-6736(08)60383-9 10.1189/jlb.0306173 10.1186/s12876-020-1158-y 10.1001/jamaoncol.2018.4154 10.1128/JVI.74.9.4165-4173.2000 10.1053/jhep.2000.19324 10.1053/j.gastro.2012.06.009 10.1128/jvi.69.10.6158-6169.1995 10.1016/j.cell.2015.03.005 10.1016/j.immuni.2016.04.008 10.1073/pnas.0504273102 10.4049/jimmunol.169.9.5188 10.1111/j.1537-2995.1963.tb04673.x 10.1016/j.jhep.2016.07.011 10.1371/journal.ppat.1003490 10.1093/intimm/11.8.1225 10.1128/JVI.74.5.2255-2264.2000 10.1038/srep07341 10.1084/jem.191.7.1247 10.1128/JVI.02844-06 10.1016/0092-8674(89)90770-8 10.1038/gt.2008.60 10.1016/j.jhep.2015.01.018 10.1002/hep.21378 10.1128/JVI.73.1.474-481.1999 10.1016/j.coi.2015.06.016 10.1084/jem.20191247 10.1038/s41575-019-0196-9 10.1038/nm866 10.1002/hep.23778 10.3390/genes9070365 10.1111/liv.14364 10.1001/jama.2018.3795 10.1016/j.molimm.2012.10.032 10.1038/nrdp.2018.35 10.1016/j.virol.2015.02.031 10.1128/JVI.73.12.9710-9717.1999 10.3390/v9040075 10.1128/JVI.77.1.68-76.2003 10.1126/sciimmunol.aba2351 10.1128/JVI.00867-09 10.1126/science.3491425 10.1084/jem.193.7.847 10.1084/jem.188.2.341 10.1128/JVI.02007-17 10.1016/S0140-6736(73)92004-7 10.1158/0008-5472.CAN-03-3817 10.1073/pnas.172521999 10.1016/j.annonc.2020.02.012 10.1016/B978-0-12-394316-3.00004-1 10.1038/ni.2691 10.1016/j.jhep.2020.01.024 10.1002/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L 10.1002/hep.21896 10.1016/S0264-410X(02)00392-4 10.1189/jlb.4MR0415-150R 10.1128/JVI.73.7.5767-5776.1999 10.1001/jamainternmed.2018.8342 10.3389/fimmu.2020.00849 10.1136/gutjnl-2018-316644 10.1128/JVI.01457-18 10.1038/cmi.2015.112 10.1084/jem.180.3.933 10.1016/j.coviro.2016.06.003 10.1016/0168-8278(95)80226-6 10.1172/JCI121957 10.1038/nm1317 10.1007/s10555-017-9675-z 10.1146/annurev-virology-012420-024942 |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2021 2021. Springer Nature Limited. Springer Nature Limited 2021. |
| Copyright_xml | – notice: Springer Nature Limited 2021 – notice: 2021. Springer Nature Limited. – notice: Springer Nature Limited 2021. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QR 7RV 7T5 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7N M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1038/s41577-021-00549-4 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Chemoreception Abstracts Nursing & Allied Health Database Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (Proquest) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1474-1741 |
| EndPage | 32 |
| ExternalDocumentID | 34002067 10_1038_s41577_021_00549_4 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- .55 0R~ 123 29M 36B 39C 3V. 4.4 53G 70F 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAEEF AARCD AAWYQ AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABNNU ABUWG ACGFS ACIWK ACPRK ACRPL ACUHS ADBBV ADNMO AENEX AEUYN AFBBN AFKRA AFRAH AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN B0M BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EBC EBD EBS EE. EJD EMB EMK EMOBN EPL ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IHR IHW INH INR ISR ITC L-9 LK8 M1P M7P N9A NAPCQ NNMJJ O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RNR RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WOW X7M ~8M AAYXX ABFSG ACSTC AEZWR AFANA AFHIU AGSTI AHWEU AIXLP ALPWD ATHPR CITATION AGQPQ CGR CUY CVF ECM EIF NFIDA NPM PHGZM PHGZT PJZUB PPXIY PQGLB 7QR 7T5 7U9 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c441t-c701e582cb5ecf6a084ff133f57d9b64343c696206755af79f72bc1cff7a70a93 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 347 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000651329800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1474-1733 1474-1741 |
| IngestDate | Wed Oct 01 13:33:48 EDT 2025 Sun Nov 30 04:46:43 EST 2025 Mon Jul 21 05:55:54 EDT 2025 Sat Nov 29 06:24:32 EST 2025 Tue Nov 18 22:18:31 EST 2025 Fri Feb 21 02:37:49 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2021. Springer Nature Limited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c441t-c701e582cb5ecf6a084ff133f57d9b64343c696206755af79f72bc1cff7a70a93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-9370-2671 0000-0002-0205-2678 |
| PMID | 34002067 |
| PQID | 2616475247 |
| PQPubID | 27582 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_2528820970 proquest_journals_2616475247 pubmed_primary_34002067 crossref_citationtrail_10_1038_s41577_021_00549_4 crossref_primary_10_1038_s41577_021_00549_4 springer_journals_10_1038_s41577_021_00549_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature reviews. Immunology |
| PublicationTitleAbbrev | Nat Rev Immunol |
| PublicationTitleAlternate | Nat Rev Immunol |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Thimme (CR41) 2003; 77 Neumann (CR71) 2010; 52 Revill (CR4) 2019; 4 Kakimi, Isogawa, Chung, Sette, Chisari (CR56) 2002; 76 Schuch (CR66) 2019; 68 Martinez, Villeret, Testoni, Zoulim (CR136) 2020; 40 Reignat (CR109) 2002; 195 Hu, Liu (CR144) 2017; 9 Budzinska, Shackel, Urban, Tu (CR154) 2018; 9 Tu (CR13) 2018; 92 Bertoletti, Kennedy (CR76) 2015; 12 Tu (CR160) 2015; 22 Locarnini, Hatzakis, Chen, Lok (CR2) 2015; 62 Wooddell (CR16) 2017; 9 Bataller, Brenner (CR122) 2005; 115 Ornelas (CR125) 2017; 36 Sitia (CR104) 2007; 81 Walter, Keist, Niederöst, Pult, Blum (CR138) 1996; 24 Yuen (CR3) 2018; 4 Iannacone, Sitia, Narvaiza, Ruggeri, Guidotti (CR19) 2007; 14 Hillis (CR137) 1963; 3 Maini (CR108) 2000; 191 Summers (CR14) 2003; 100 Guidotti, McClary, Loudis, Chisari (CR95) 2000; 191 Shimizu, Guidotti, Fowler, Chisari (CR55) 1998; 161 Maini, Burton (CR43) 2019; 16 Wieland, Spangenberg, Thimme, Purcell, Chisari (CR27) 2004; 101 Kennedy (CR54) 2012; 143 Isogawa, Robek, Furuichi, Chisari (CR37) 2005; 79 Rivino (CR65) 2018; 128 Kimura, Kakimi, Wieland, Guidotti, Chisari (CR35) 2002; 169 Kim, Tilles (CR9) 1973; 52 Nakamoto, Guidotti, Pasquetto, Schreiber, Chisari (CR102) 1997; 158 Sitia (CR106) 2004; 113 Chen (CR60) 2004; 101 Simon (CR129) 2018; 4 Asabe (CR21) 2009; 83 Wieland, Guidotti, Chisari (CR34) 2000; 74 Bertoletti, Ferrari (CR11) 2016; 64 Pallett (CR100) 2017; 214 Hayashi (CR134) 2020; 12 Vollmar, Menger (CR23) 2009; 89 Wieland, Thimme, Purcell, Chisari (CR28) 2004; 101 Fumagalli (CR67) 2020; 217 Webster (CR40) 2000; 32 Sureau, Salisse (CR140) 2013; 57 Roskams (CR141) 1995; 21 Ando (CR101) 1994; 152 Jilbert, Miller, Scougall, Turnbull, Burrell (CR20) 1996; 226 Guidotti, Matzke, Schaller, Chisari (CR25) 1995; 69 Schuppan, Afdhal (CR121) 2008; 371 Hoofnagle, Gerety, Barker (CR42) 1973; 302 Salimzadeh (CR79) 2018; 128 Tian, Kuo, Akbari, Ou (CR62) 2016; 44 Li (CR69) 2017; 6 Friedman (CR123) 2004; 1 Ficht, Iannacone (CR147) 2020; 5 Iannacone (CR86) 2015; 12 Guidotti (CR45) 1996; 4 Bénéchet (CR48) 2019; 574 Michalak, Pasquinelli, Guilhot, Chisari (CR99) 1994; 93 Iwasaki (CR39) 2012; 66 West (CR52) 2013; 123 Guidotti (CR44) 1994; 91 Suslov (CR29) 2018; 154 Chen (CR61) 2005; 79 Benechet, Iannacone (CR88) 2017; 66 Iannacone (CR124) 2005; 11 Bertoletti (CR74) 1994; 369 Guidotti, Iannacone (CR85) 2013; 55 Bert (CR82) 2019; 72 Hadziyannis, Gerber, Vissoulis, Popper (CR159) 1973; 96 Vilarinho, Ogasawara, Nishimura, Lanier, Baron (CR36) 2007; 104 Wieland, Eustaquio, Whitten-Bauer, Boyd, Chisari (CR96) 2005; 102 Warren (CR91) 2006; 44 Wieland (CR59) 2015; 5 Seitz, Habjanič, Schütz, Bartenschlager (CR145) 2020; 7 Jenne, Kubes (CR149) 2013; 14 Maini (CR75) 2000; 30 Tu, Budzinska, Shackel, Urban (CR153) 2017; 9 Horst, Neumann, Diehl, Tiegs (CR150) 2016; 13 Tsui, Guidotti, Ishikawa, Chisari (CR30) 1995; 92 Isogawa, Furuichi, Chisari (CR114) 2005; 23 Hwang, Chang, Kim, Park (CR128) 2018; 8 Schulze, Gripon, Urban (CR139) 2007; 46 Tang, Covert, Wilson, Kottilil (CR117) 2018; 319 Guidotti, Vecchia, Colombo (CR135) 2020; 159 Udompap, Kim (CR5) 2020; 15 Seeger, Mason (CR10) 2015; 479 Vanwolleghem (CR83) 2020; 73 Bisceglie (CR120) 2009; 49 Levrero, Testoni, Zoulim (CR6) 2016; 18 Lee (CR127) 2016; 23 Burton (CR78) 2018; 128 Fisicaro (CR77) 2020; 11 Wisse, Jacobs, Topal, Frederik, Geest (CR22) 2008; 15 Robek, Wieland, Chisari (CR97) 2002; 76 Heise, Guidotti, Cavanaugh, Chisari (CR31) 1999; 73 Yan (CR142) 2012; 1 Guidotti (CR89) 2015; 161 Yang, Summers (CR15) 1999; 73 Chisari (CR157) 1989; 59 Simon (CR17) 2020; 382 Bertolino (CR49) 1999; 11 Su, Wang, Wu, Huang (CR158) 2008; 23 Buendia, Neuveut (CR118) 2015; 5 Blattman (CR51) 2003; 9 Tian (CR80) 2018; 7 Webster (CR110) 2004; 78 Liao (CR132) 2020; 20 Milich, McLachlan (CR84) 1986; 234 Wong, McCaughan, Bowen, Bertolino (CR151) 2016; 5 Boni (CR111) 2007; 81 Mason (CR152) 2016; 151 Guidotti, Chisari (CR1) 2006; 1 Wisse, de Zanger, Charels, Van Der Smissen, McCuskey (CR146) 1985; 5 Sitia (CR18) 2012; 109 Bertoletti (CR73) 1994; 180 Sironi (CR90) 2014; 4 Nakamoto, Guidotti, Kuhlen, Fowler, Chisari (CR113) 1998; 188 Kuipery, Gehring, Isogawa (CR53) 2020; 179 Fioravanti (CR93) 2017; 67 Lee (CR130) 2019; 179 Isogawa (CR47) 2013; 9 Guidotti, Isogawa, Chisari (CR12) 2015; 36 Whalley (CR24) 2001; 193 Dienes (CR156) 1990; 98 Fisicaro (CR58) 2017; 23 Bert (CR68) 2020; 159 Publicover (CR63) 2013; 123 Sitia (CR105) 2002; 99 Zhang (CR70) 2015; 65 Kakimi (CR107) 2001; 194 Iannacone, Guidotti (CR94) 2015; 5 Inverso, Iannacone (CR87) 2016; 99 Hoogeveen (CR112) 2018; 68 Xia (CR98) 2016; 150 Guidotti (CR26) 1999; 284 Brunetto (CR64) 1991; 88 Pol (CR50) 2020; 217 Xu (CR81) 2015; 12 McClary, Koch, Chisari, Guidotti (CR33) 2000; 74 Wang (CR131) 2019; 151 Sitia (CR103) 2011; 7 Khakpoor (CR115) 2018; 93 Rehermann, Ferrari, Pasquinelli, Chisari (CR8) 1996; 2 Bosetti, Santucci, Gallus, Martinetti, Vecchia (CR133) 2020; 31 Heise, Guidotti, Chisari (CR32) 1999; 73 Wong, Tay, McCaughan, Bowen, Bertolino (CR46) 2015; 63 Haemmerle, Stone, Menter, Afshar-Kharghan, Sood (CR126) 2018; 33 Döring, Lütteke, Geyer, Petzinger (CR143) 2012; 70 Iwakiri (CR148) 2016; 64 Suslov, Wieland, Menne (CR38) 2018; 30 Ishak (CR57) 1995; 22 Galun (CR72) 2002; 35 Huang, Yen (CR155) 1993; 67 Levrero, Zucman-Rossi (CR119) 2016; 64 Fanning, Zoulim, Hou, Bertoletti (CR7) 2019; 18 Guidotti (CR92) 2002; 20 Nakamoto, Suda, Momoi, Kaneko (CR116) 2004; 64 E Walter (549_CR138) 1996; 24 YC Wong (549_CR151) 2016; 5 J Fioravanti (549_CR93) 2017; 67 MK Maini (549_CR108) 2000; 191 WD Hillis (549_CR137) 1963; 3 J Summers (549_CR14) 2003; 100 E Wisse (549_CR146) 1985; 5 P Fisicaro (549_CR77) 2020; 11 A Bertoletti (549_CR76) 2015; 12 S Wieland (549_CR28) 2004; 101 AMD Bisceglie (549_CR120) 2009; 49 C Boni (549_CR111) 2007; 81 LG Guidotti (549_CR26) 1999; 284 MK Maini (549_CR75) 2000; 30 M Haemmerle (549_CR126) 2018; 33 K Kimura (549_CR35) 2002; 169 LG Guidotti (549_CR95) 2000; 191 MK Maini (549_CR43) 2019; 16 GC Fanning (549_CR7) 2019; 18 TI Michalak (549_CR99) 1994; 93 LJ Pallett (549_CR100) 2017; 214 AR Jilbert (549_CR20) 1996; 226 M Levrero (549_CR119) 2016; 64 J Publicover (549_CR63) 2013; 123 R Thimme (549_CR41) 2003; 77 P-C Lee (549_CR127) 2016; 23 Y Tian (549_CR62) 2016; 44 FV Chisari (549_CR157) 1989; 59 P Bertolino (549_CR49) 1999; 11 A Bertoletti (549_CR74) 1994; 369 A Ornelas (549_CR125) 2017; 36 LG Guidotti (549_CR1) 2006; 1 A Suslov (549_CR38) 2018; 30 T-Y Lee (549_CR130) 2019; 179 T Hayashi (549_CR134) 2020; 12 V Fumagalli (549_CR67) 2020; 217 Y Shimizu (549_CR55) 1998; 161 T-Y Zhang (549_CR70) 2015; 65 B Döring (549_CR143) 2012; 70 S Locarnini (549_CR2) 2015; 62 L Sironi (549_CR90) 2014; 4 SL Friedman (549_CR123) 2004; 1 S Asabe (549_CR21) 2009; 83 T Tu (549_CR160) 2015; 22 K Ando (549_CR101) 1994; 152 S Vilarinho (549_CR36) 2007; 104 SF Wieland (549_CR59) 2015; 5 LSY Tang (549_CR117) 2018; 319 MD Robek (549_CR97) 2002; 76 SF Wieland (549_CR96) 2005; 102 RC Hoogeveen (549_CR112) 2018; 68 T Vanwolleghem (549_CR83) 2020; 73 X Xu (549_CR81) 2015; 12 J Hu (549_CR144) 2017; 9 C Seeger (549_CR10) 2015; 479 MG Martinez (549_CR136) 2020; 40 AP Bénéchet (549_CR48) 2019; 574 SA Whalley (549_CR24) 2001; 193 NL Bert (549_CR82) 2019; 72 A Khakpoor (549_CR115) 2018; 93 AK Horst (549_CR150) 2016; 13 AP Benechet (549_CR88) 2017; 66 A Kuipery (549_CR53) 2020; 179 LG Guidotti (549_CR12) 2015; 36 M Iannacone (549_CR124) 2005; 11 Li (549_CR69) 2017; 6 B Rehermann (549_CR8) 1996; 2 G Sitia (549_CR103) 2011; 7 T Heise (549_CR31) 1999; 73 R Bataller (549_CR122) 2005; 115 C Tian (549_CR80) 2018; 7 HP Dienes (549_CR156) 1990; 98 CY Kim (549_CR9) 1973; 52 PTF Kennedy (549_CR54) 2012; 143 Y Nakamoto (549_CR116) 2004; 64 M Chen (549_CR61) 2005; 79 A Bertoletti (549_CR73) 1994; 180 M Iannacone (549_CR19) 2007; 14 LG Guidotti (549_CR44) 1994; 91 B Vollmar (549_CR23) 2009; 89 L Salimzadeh (549_CR79) 2018; 128 Y-H Liao (549_CR132) 2020; 20 C Sureau (549_CR140) 2013; 57 Pol (549_CR50) 2020; 217 M-A Buendia (549_CR118) 2015; 5 S Reignat (549_CR109) 2002; 195 NL Bert (549_CR68) 2020; 159 G Sitia (549_CR18) 2012; 109 D Milich (549_CR84) 1986; 234 A Warren (549_CR91) 2006; 44 TG Simon (549_CR129) 2018; 4 PA Revill (549_CR4) 2019; 4 LG Guidotti (549_CR45) 1996; 4 TG Simon (549_CR17) 2020; 382 MR Brunetto (549_CR64) 1991; 88 Sitia (549_CR104) 2007; 81 X Ficht (549_CR147) 2020; 5 WS Mason (549_CR152) 2016; 151 K Kakimi (549_CR107) 2001; 194 P Udompap (549_CR5) 2020; 15 GJM Webster (549_CR110) 2004; 78 I Su (549_CR158) 2008; 23 A Schulze (549_CR139) 2007; 46 G Sitia (549_CR106) 2004; 113 C Bosetti (549_CR133) 2020; 31 JH Hoofnagle (549_CR42) 1973; 302 A Iwasaki (549_CR39) 2012; 66 YC Wong (549_CR46) 2015; 63 E Galun (549_CR72) 2002; 35 SF Wieland (549_CR27) 2004; 101 MT Chen (549_CR60) 2004; 101 D Inverso (549_CR87) 2016; 99 LG Guidotti (549_CR25) 1995; 69 A Suslov (549_CR29) 2018; 154 Isogawa (549_CR47) 2013; 9 EE West (549_CR52) 2013; 123 S Wang (549_CR131) 2019; 151 G Sitia (549_CR105) 2002; 99 JN Blattman (549_CR51) 2003; 9 GJM Webster (549_CR40) 2000; 32 S Seitz (549_CR145) 2020; 7 M Iannacone (549_CR86) 2015; 12 Y Nakamoto (549_CR102) 1997; 158 LV Tsui (549_CR30) 1995; 92 A Schuch (549_CR66) 2019; 68 LG Guidotti (549_CR89) 2015; 161 MA Budzinska (549_CR154) 2018; 9 SF Wieland (549_CR34) 2000; 74 T Tu (549_CR13) 2018; 92 CN Jenne (549_CR149) 2013; 14 D Schuppan (549_CR121) 2008; 371 LG Guidotti (549_CR85) 2013; 55 M Iannacone (549_CR94) 2015; 5 S Hadziyannis (549_CR159) 1973; 96 Y Nakamoto (549_CR113) 1998; 188 Y Xia (549_CR98) 2016; 150 T Heise (549_CR32) 1999; 73 K Kakimi (549_CR56) 2002; 76 H Yan (549_CR142) 2012; 1 H McClary (549_CR33) 2000; 74 P Fisicaro (549_CR58) 2017; 23 Y Iwakiri (549_CR148) 2016; 64 K Ishak (549_CR57) 1995; 22 T Tu (549_CR153) 2017; 9 T Roskams (549_CR141) 1995; 21 LG Guidotti (549_CR135) 2020; 159 M Levrero (549_CR6) 2016; 18 W Yang (549_CR15) 1999; 73 M Isogawa (549_CR114) 2005; 23 E Wisse (549_CR22) 2008; 15 IC Hwang (549_CR128) 2018; 8 CI Wooddell (549_CR16) 2017; 9 Neumann (549_CR71) 2010; 52 A Bertoletti (549_CR11) 2016; 64 M-F Yuen (549_CR3) 2018; 4 L Rivino (549_CR65) 2018; 128 AR Burton (549_CR78) 2018; 128 LG Guidotti (549_CR92) 2002; 20 M Isogawa (549_CR37) 2005; 79 ZM Huang (549_CR155) 1993; 67 |
| References_xml | – volume: 4 start-page: 545 year: 2019 end-page: 558 ident: CR4 article-title: A global scientific strategy to cure hepatitis B publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(19)30119-0 – volume: 91 start-page: 3764 year: 1994 end-page: 3768 ident: CR44 article-title: Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.9.3764 – volume: 93 start-page: 230 year: 1994 end-page: 239 ident: CR99 article-title: Hepatitis B virus persistence after recovery from acute viral hepatitis publication-title: J. Clin. Invest. doi: 10.1172/JCI116950 – volume: 21 start-page: 950 year: 1995 end-page: 958 ident: CR141 article-title: Heparan sulfate proteoglycan expression in normal human liver publication-title: Hepatology doi: 10.1002/hep.1840210410 – volume: 18 start-page: 827 year: 2019 end-page: 844 ident: CR7 article-title: Therapeutic strategies for hepatitis B virus infection: towards a cure publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-019-0037-0 – volume: 104 start-page: 18187 year: 2007 end-page: 18192 ident: CR36 article-title: Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0708968104 – volume: 30 start-page: 9 year: 2018 end-page: 17 ident: CR38 article-title: Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2018.01.008 – volume: 214 start-page: 1567 year: 2017 end-page: 1580 ident: CR100 article-title: IL-2 tissue-resident T cells in the human liver: sentinels for hepatotropic infection publication-title: J. Exp. Med. doi: 10.1084/jem.20162115 – volume: 101 start-page: 2129 year: 2004 end-page: 2134 ident: CR27 article-title: Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0308478100 – volume: 161 start-page: 4520 year: 1998 end-page: 4529 ident: CR55 article-title: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice publication-title: J. Immunol. doi: 10.4049/jimmunol.161.9.4520 – volume: 1 year: 2012 ident: CR142 article-title: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus publication-title: eLife doi: 10.7554/eLife.00049 – volume: 2 start-page: 1104 year: 1996 end-page: 1108 ident: CR8 article-title: The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response publication-title: Nat. Med. doi: 10.1038/nm1096-1104 – volume: 88 start-page: 4186 year: 1991 end-page: 4190 ident: CR64 article-title: Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.88.10.4186 – volume: 52 start-page: 1176 year: 1973 end-page: 1186 ident: CR9 article-title: Purification and biophysical characterization of hepatitis B antigen publication-title: J. Clin. Invest. doi: 10.1172/JCI107284 – volume: 5 start-page: 683 year: 1985 end-page: 692 ident: CR146 article-title: The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse publication-title: Hepatology doi: 10.1002/hep.1840050427 – volume: 191 start-page: 1269 year: 2000 end-page: 1280 ident: CR108 article-title: The role of virus-specific CD8 cells in liver damage and viral control during persistent hepatitis B virus infection publication-title: J. Exp. Med. doi: 10.1084/jem.191.8.1269 – volume: 5 year: 2016 ident: CR151 article-title: The CD8 T-cell response during tolerance induction in liver transplantation publication-title: Clin. Transl Immunol. doi: 10.1038/cti.2016.53 – volume: 195 start-page: 1089 year: 2002 end-page: 1101 ident: CR109 article-title: Escaping high viral load exhaustion CD8 cells with altered tetramer binding in chronic hepatitis B virus infection publication-title: J. Exp. Med. doi: 10.1084/jem.20011723 – volume: 64 start-page: S71 year: 2016 end-page: S83 ident: CR11 article-title: Adaptive immunity in HBV infection publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.01.026 – volume: 151 start-page: 986 year: 2016 end-page: 998.e4 ident: CR152 article-title: HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.07.012 – volume: 14 start-page: 1532 year: 2007 end-page: 1535 ident: CR19 article-title: Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus publication-title: Clin. Vaccine Immunol. doi: 10.1128/CVI.00298-07 – volume: 22 start-page: 737 year: 2015 end-page: 753 ident: CR160 article-title: Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection publication-title: J. Viral Hepat. doi: 10.1111/jvh.12380 – volume: 109 start-page: E2165 year: 2012 end-page: E2172 ident: CR18 article-title: Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1209182109 – volume: 1 start-page: 98 year: 2004 end-page: 105 ident: CR123 article-title: Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications publication-title: Nat. Clin. Pract. Gastr – volume: 92 start-page: 12398 year: 1995 end-page: 12402 ident: CR30 article-title: Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.92.26.12398 – volume: 5 start-page: a021477 year: 2015 ident: CR94 article-title: Mouse models of hepatitis B virus pathogenesis publication-title: CSH Perspect. Med. – volume: 113 start-page: 1158 year: 2004 end-page: 1167 ident: CR106 article-title: MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs publication-title: J. Clin. Invest. doi: 10.1172/JCI200421087 – volume: 4 start-page: 25 year: 1996 end-page: 36 ident: CR45 article-title: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes publication-title: Immunity doi: 10.1016/S1074-7613(00)80295-2 – volume: 101 start-page: 6669 year: 2004 end-page: 6674 ident: CR28 article-title: Genomic analysis of the host response to hepatitis B virus infection publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0401771101 – volume: 24 start-page: 1 year: 1996 end-page: 5 ident: CR138 article-title: Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo publication-title: Hepatology – volume: 35 start-page: 673 year: 2002 end-page: 679 ident: CR72 article-title: Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties publication-title: Hepatology doi: 10.1053/jhep.2002.31867 – volume: 369 start-page: 407 year: 1994 end-page: 410 ident: CR74 article-title: Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells publication-title: Nature doi: 10.1038/369407a0 – volume: 96 start-page: 327 year: 1973 end-page: 330 ident: CR159 article-title: Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers publication-title: Arch. Pathol. – volume: 8 year: 2018 ident: CR128 article-title: Aspirin use and risk of hepatocellular carcinoma in a national cohort study of Korean adults publication-title: Sci. Rep. doi: 10.1038/s41598-018-23343-0 – volume: 284 start-page: 825 year: 1999 end-page: 829 ident: CR26 article-title: Viral clearance without destruction of infected cells during acute HBV infection publication-title: Science doi: 10.1126/science.284.5415.825 – volume: 101 start-page: 14913 year: 2004 end-page: 14918 ident: CR60 article-title: A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0406282101 – volume: 128 start-page: 4588 year: 2018 end-page: 4603 ident: CR78 article-title: Circulating and intrahepatic antiviral B cells are defective in hepatitis B publication-title: J. Clin. Invest. doi: 10.1172/JCI121960 – volume: 23 start-page: 327 year: 2017 end-page: 336 ident: CR58 article-title: Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B publication-title: Nat. Med. doi: 10.1038/nm.4275 – volume: 89 start-page: 1269 year: 2009 end-page: 1339 ident: CR23 article-title: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair publication-title: Physiol. Rev. doi: 10.1152/physrev.00027.2008 – volume: 12 start-page: 309 year: 2015 end-page: 316 ident: CR81 article-title: Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2015.25 – volume: 57 start-page: 985 year: 2013 end-page: 994 ident: CR140 article-title: A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant publication-title: Hepatology doi: 10.1002/hep.26125 – volume: 63 start-page: 1005 year: 2015 end-page: 1014 ident: CR46 article-title: Immune outcomes in the liver: is CD8 T cell fate determined by the environment? publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.05.033 – volume: 100 start-page: 11652 year: 2003 end-page: 11659 ident: CR14 article-title: Hepatocyte turnover during resolution of a transient hepadnaviral infection publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1635109100 – volume: 72 start-page: 34 year: 2019 end-page: 44 ident: CR82 article-title: Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.07.015 – volume: 194 start-page: 1755 year: 2001 end-page: 1766 ident: CR107 article-title: Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes publication-title: J. Exp. Med. doi: 10.1084/jem.194.12.1755 – volume: 65 start-page: 658 year: 2015 ident: CR70 article-title: Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen publication-title: Gut doi: 10.1136/gutjnl-2014-308964 – volume: 23 start-page: 874 year: 2016 end-page: 883 ident: CR127 article-title: Antiplatelet therapy is associated with a better prognosis for patients with hepatitis B virus-related hepatocellular carcinoma after liver resection publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-016-5520-9 – volume: 1 start-page: 23 year: 2006 end-page: 61 ident: CR1 article-title: Immunobiology and pathogenesis of viral hepatitis publication-title: Annu. Rev. Pathol. Mech. Dis. doi: 10.1146/annurev.pathol.1.110304.100230 – volume: 179 start-page: 104816 year: 2020 ident: CR53 article-title: Mechanisms of HBV immune evasion publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2020.104816 – volume: 49 start-page: S56 year: 2009 end-page: S60 ident: CR120 article-title: Hepatitis B and hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.22962 – volume: 123 start-page: 3728 year: 2013 end-page: 3739 ident: CR63 article-title: Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B publication-title: J. Clin. Invest. doi: 10.1172/JCI68182 – volume: 6 year: 2017 ident: CR69 article-title: A potent human neutralizing antibody Fc-dependently reduces established HBV infections publication-title: eLife doi: 10.7554/eLife.26738 – volume: 5 start-page: a021444 year: 2015 ident: CR118 article-title: Hepatocellular carcinoma publication-title: CSH Perspect. Med. – volume: 9 year: 2017 ident: CR16 article-title: RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aan0241 – volume: 152 start-page: 3245 year: 1994 end-page: 3253 ident: CR101 article-title: Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo publication-title: J. Immunol. doi: 10.4049/jimmunol.152.7.3245 – volume: 158 start-page: 5692 year: 1997 end-page: 5697 ident: CR102 article-title: Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice publication-title: J. Immunol. doi: 10.4049/jimmunol.158.12.5692 – volume: 98 start-page: 1017 year: 1990 end-page: 1023 ident: CR156 article-title: Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90028-Y – volume: 76 start-page: 3570 year: 2002 end-page: 3574 ident: CR97 article-title: Inhibition of hepatitis B virus replication by interferon requires proteasome activity publication-title: J. Virol. doi: 10.1128/JVI.76.7.3570-3574.2002 – volume: 7 start-page: 16 year: 2018 ident: CR80 article-title: Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans publication-title: Emerg. Microbes Infec doi: 10.1038/s41426-018-0034-0 – volume: 64 start-page: S84 year: 2016 end-page: S101 ident: CR119 article-title: Mechanisms of HBV-induced hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.021 – volume: 23 start-page: 53 year: 2005 end-page: 63 ident: CR114 article-title: Oscillating CD8 T cell effector functions after antigen recognition in the liver publication-title: Immunity doi: 10.1016/j.immuni.2005.05.005 – volume: 67 start-page: 7032 year: 1993 end-page: 7040 ident: CR155 article-title: Dysregulated surface gene expression from disrupted hepatitis B virus genomes publication-title: J. Virol. doi: 10.1128/jvi.67.12.7032-7040.1993 – volume: 382 start-page: 1018 year: 2020 end-page: 1028 ident: CR17 article-title: Association of aspirin with hepatocellular carcinoma and liver-related mortality publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1912035 – volume: 12 start-page: 269 year: 2015 end-page: 272 ident: CR86 article-title: Hepatic effector CD8 T-cell dynamics publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2014.78 – volume: 67 start-page: 543 year: 2017 end-page: 548 ident: CR93 article-title: Effector CD8 T cell-derived interleukin-10 enhances acute liver immunopathology publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.04.020 – volume: 7 year: 2011 ident: CR103 article-title: Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1002061 – volume: 12 start-page: 3215 year: 2020 ident: CR134 article-title: Antiplatelet therapy improves the prognosis of patients with hepatocellular carcinoma publication-title: Cancers doi: 10.3390/cancers12113215 – volume: 78 start-page: 5707 year: 2004 end-page: 5719 ident: CR110 article-title: Longitudinal analysis of CD8 T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy publication-title: J. Virol. doi: 10.1128/JVI.78.11.5707-5719.2004 – volume: 79 start-page: 7269 year: 2005 end-page: 7272 ident: CR37 article-title: Toll-like receptor signaling inhibits hepatitis B virus replication in vivo publication-title: J. Virol. doi: 10.1128/JVI.79.11.7269-7272.2005 – volume: 66 start-page: 177 year: 2012 end-page: 196 ident: CR39 article-title: A virological view of innate immune recognition publication-title: Annu. Rev. Microbiol. doi: 10.1146/annurev-micro-092611-150203 – volume: 33 start-page: 965 year: 2018 end-page: 983 ident: CR126 article-title: The platelet lifeline to cancer: challenges and opportunities publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.03.002 – volume: 9 start-page: 56 year: 2017 ident: CR144 article-title: Complete and incomplete hepatitis B virus particles: formation, function, and application publication-title: Viruses doi: 10.3390/v9030056 – volume: 154 start-page: 1778 year: 2018 end-page: 1790 ident: CR29 article-title: Virus does not interfere with innate immune responses in the human liver publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.01.034 – volume: 115 start-page: 209 year: 2005 end-page: 218 ident: CR122 article-title: Liver fibrosis publication-title: J. Clin. Invest. doi: 10.1172/JCI24282 – volume: 159 start-page: 652 year: 2020 end-page: 664 ident: CR68 article-title: Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.04.019 – volume: 79 start-page: 3016 year: 2005 end-page: 3027 ident: CR61 article-title: Immune tolerance split between hepatitis B virus precore and core proteins publication-title: J. Virol. doi: 10.1128/JVI.79.5.3016-3027.2005 – volume: 123 start-page: 2604 year: 2013 end-page: 2615 ident: CR52 article-title: PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells publication-title: J. Clin. Invest. doi: 10.1172/JCI67008 – volume: 150 start-page: 194 year: 2016 end-page: 205 ident: CR98 article-title: Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.09.026 – volume: 217 year: 2020 ident: CR67 article-title: Serum HBsAg clearance has minimal impact on CD8 T cell responses in mouse models of HBV infection publication-title: J. Exp. Med. doi: 10.1084/jem.20200298 – volume: 23 start-page: 1169 year: 2008 end-page: 1174 ident: CR158 article-title: Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection publication-title: J. Gastroen Hepatol. doi: 10.1111/j.1440-1746.2008.05348.x – volume: 226 start-page: 338 year: 1996 end-page: 345 ident: CR20 article-title: Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks publication-title: Virology doi: 10.1006/viro.1996.0661 – volume: 12 start-page: 258 year: 2015 end-page: 263 ident: CR76 article-title: The immune tolerant phase of chronic HBV infection: new perspectives on an old concept publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2014.79 – volume: 76 start-page: 8609 year: 2002 end-page: 8620 ident: CR56 article-title: Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections publication-title: J. Virol. doi: 10.1128/JVI.76.17.8609-8620.2002 – volume: 64 start-page: 706 year: 2016 end-page: 707 ident: CR148 article-title: The lymphatic system: a new frontier in hepatology publication-title: Hepatology doi: 10.1002/hep.28650 – volume: 68 start-page: 905 year: 2019 end-page: 915 ident: CR66 article-title: Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8 T cells in chronically HBV-infected patients with low viral load publication-title: Gut doi: 10.1136/gutjnl-2018-316641 – volume: 151 start-page: 104585 year: 2019 ident: CR131 article-title: Association of aspirin therapy with risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with 2.5 million participants publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104585 – volume: 15 start-page: 85 year: 2020 end-page: 90 ident: CR5 article-title: Development of hepatocellular carcinoma in patients with suppressed viral replication: changes in risk over time publication-title: Clin. Liver Dis. doi: 10.1002/cld.904 – volume: 574 start-page: 200 year: 2019 end-page: 205 ident: CR48 article-title: Dynamics and genomic landscape of CD8 T cells undergoing hepatic priming publication-title: Nature doi: 10.1038/s41586-019-1620-6 – volume: 128 start-page: 668 year: 2018 end-page: 681 ident: CR65 article-title: Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation publication-title: J. Clin. Invest. doi: 10.1172/JCI92812 – volume: 159 start-page: 1988 year: 2020 end-page: 1990 ident: CR135 article-title: Is it time to recommend low-dose aspirin treatment for the prevention of hepatocellular carcinoma? publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.09.007 – volume: 371 start-page: 838 year: 2008 end-page: 851 ident: CR121 article-title: Liver cirrhosis publication-title: Lancet doi: 10.1016/S0140-6736(08)60383-9 – volume: 81 start-page: 100 year: 2007 end-page: 107 ident: CR104 article-title: Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0306173 – volume: 20 start-page: 6 year: 2020 ident: CR132 article-title: Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study publication-title: BMC Gastroenterol. doi: 10.1186/s12876-020-1158-y – volume: 4 start-page: 1683 year: 2018 ident: CR129 article-title: Association between aspirin use and risk of hepatocellular carcinoma publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2018.4154 – volume: 74 start-page: 4165 year: 2000 end-page: 4173 ident: CR34 article-title: Intrahepatic induction of α/β interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice publication-title: J. Virol. doi: 10.1128/JVI.74.9.4165-4173.2000 – volume: 32 start-page: 1117 year: 2000 end-page: 1124 ident: CR40 article-title: Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms publication-title: Hepatology doi: 10.1053/jhep.2000.19324 – volume: 143 start-page: 637 year: 2012 end-page: 645 ident: CR54 article-title: Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.06.009 – volume: 69 start-page: 6158 year: 1995 end-page: 6169 ident: CR25 article-title: High-level hepatitis B virus replication in transgenic mice publication-title: J. Virol. doi: 10.1128/jvi.69.10.6158-6169.1995 – volume: 161 start-page: 486 year: 2015 end-page: 500 ident: CR89 article-title: Immunosurveillance of the liver by intravascular effector CD8 T cells publication-title: Cell doi: 10.1016/j.cell.2015.03.005 – volume: 44 start-page: 1204 year: 2016 end-page: 1214 ident: CR62 article-title: Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission publication-title: Immunity doi: 10.1016/j.immuni.2016.04.008 – volume: 102 start-page: 9913 year: 2005 end-page: 9917 ident: CR96 article-title: Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0504273102 – volume: 169 start-page: 5188 year: 2002 end-page: 5195 ident: CR35 article-title: Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice publication-title: J. Immunol. doi: 10.4049/jimmunol.169.9.5188 – volume: 3 start-page: 445 year: 1963 end-page: 454 ident: CR137 article-title: Viral hepatitis associated with sub-human primates publication-title: Transfusion doi: 10.1111/j.1537-2995.1963.tb04673.x – volume: 66 start-page: 228 year: 2017 end-page: 233 ident: CR88 article-title: Determinants of hepatic effector CD8 T cell dynamics publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.07.011 – volume: 9 year: 2013 ident: CR47 article-title: CD40 activation rescues antiviral CD8 T cells from PD-1-mediated exhaustion publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003490 – volume: 11 start-page: 1225 year: 1999 end-page: 1238 ident: CR49 article-title: Death by neglect as a deletional mechanism of peripheral tolerance publication-title: Int. Immunol. doi: 10.1093/intimm/11.8.1225 – volume: 74 start-page: 2255 year: 2000 end-page: 2264 ident: CR33 article-title: Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines publication-title: J. Virol. doi: 10.1128/JVI.74.5.2255-2264.2000 – volume: 4 year: 2014 ident: CR90 article-title: In vivo flow mapping in complex vessel networks by single image correlation publication-title: Sci. Rep. doi: 10.1038/srep07341 – volume: 191 start-page: 1247 year: 2000 end-page: 1252 ident: CR95 article-title: Nitric oxide inhibits hepatitis b virus replication in the livers of transgenic mice publication-title: J. Exp. Med. doi: 10.1084/jem.191.7.1247 – volume: 81 start-page: 4215 year: 2007 end-page: 4225 ident: CR111 article-title: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection publication-title: J. Virol. doi: 10.1128/JVI.02844-06 – volume: 59 start-page: 1145 year: 1989 end-page: 1156 ident: CR157 article-title: Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice publication-title: Cell doi: 10.1016/0092-8674(89)90770-8 – volume: 15 start-page: 1193 year: 2008 end-page: 1199 ident: CR22 article-title: The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer publication-title: Gene Ther. doi: 10.1038/gt.2008.60 – volume: 62 start-page: S76 year: 2015 end-page: S86 ident: CR2 article-title: Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.01.018 – volume: 44 start-page: 1182 year: 2006 end-page: 1190 ident: CR91 article-title: T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells publication-title: Hepatology doi: 10.1002/hep.21378 – volume: 73 start-page: 474 year: 1999 end-page: 481 ident: CR31 article-title: Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice publication-title: J. Virol. doi: 10.1128/JVI.73.1.474-481.1999 – volume: 36 start-page: 61 year: 2015 end-page: 66 ident: CR12 article-title: Host–virus interactions in hepatitis B virus infection publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2015.06.016 – volume: 217 start-page: 2261 year: 2020 ident: CR50 article-title: Effects of interleukin-2 in immunostimulation and immunosuppression publication-title: J. Exp. Med. doi: 10.1084/jem.20191247 – volume: 16 start-page: 662 year: 2019 end-page: 675 ident: CR43 article-title: Restoring, releasing or replacing adaptive immunity in chronic hepatitis B publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-019-0196-9 – volume: 9 start-page: 540 year: 2003 end-page: 547 ident: CR51 article-title: Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo publication-title: Nat. Med. doi: 10.1038/nm866 – volume: 5 start-page: a021469 year: 2015 ident: CR59 article-title: The chimpanzee model for hepatitis B virus infection publication-title: CSH Perspect. Med. – volume: 52 start-page: 875 year: 2010 end-page: 885 ident: CR71 article-title: Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells publication-title: Hepatology doi: 10.1002/hep.23778 – volume: 9 start-page: 365 year: 2018 ident: CR154 article-title: Cellular genomic sites of hepatitis B virus DNA integration publication-title: Genes doi: 10.3390/genes9070365 – volume: 40 start-page: 27 year: 2020 end-page: 34 ident: CR136 article-title: Can we cure hepatitis B virus with novel direct-acting antivirals? publication-title: Liver Int. doi: 10.1111/liv.14364 – volume: 319 start-page: 1802 year: 2018 end-page: 1813 ident: CR117 article-title: Chronic hepatitis B infection: a review publication-title: JAMA doi: 10.1001/jama.2018.3795 – volume: 55 start-page: 94 year: 2013 end-page: 99 ident: CR85 article-title: Effector CD8 T cell trafficking within the liver publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2012.10.032 – volume: 4 start-page: 18035 year: 2018 ident: CR3 article-title: Hepatitis B virus infection publication-title: Nat. Rev. Dis. Primers doi: 10.1038/nrdp.2018.35 – volume: 479 start-page: 672 year: 2015 end-page: 686 ident: CR10 article-title: Molecular biology of hepatitis B virus infection publication-title: Virology doi: 10.1016/j.virol.2015.02.031 – volume: 73 start-page: 9710 year: 1999 end-page: 9717 ident: CR15 article-title: Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor publication-title: J. Virol. doi: 10.1128/JVI.73.12.9710-9717.1999 – volume: 9 start-page: 75 year: 2017 ident: CR153 article-title: HBV DNA integration: molecular mechanisms and clinical implications publication-title: Viruses doi: 10.3390/v9040075 – volume: 77 start-page: 68 year: 2003 end-page: 76 ident: CR41 article-title: CD8 T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection publication-title: J. Virol. doi: 10.1128/JVI.77.1.68-76.2003 – volume: 7 start-page: 1 year: 2020 end-page: 26 ident: CR145 article-title: The hepatitis B virus envelope proteins: molecular gymnastics throughout the viral life cycle publication-title: Ann. Rev. Virol. – volume: 5 year: 2020 ident: CR147 article-title: Immune surveillance of the liver by T cells publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.aba2351 – volume: 83 start-page: 9652 year: 2009 end-page: 9662 ident: CR21 article-title: The size of the viral inoculum contributes to the outcome of hepatitis B virus infection publication-title: J. Virol. doi: 10.1128/JVI.00867-09 – volume: 234 start-page: 1398 year: 1986 end-page: 1401 ident: CR84 article-title: The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen publication-title: Science doi: 10.1126/science.3491425 – volume: 193 start-page: 847 year: 2001 end-page: 854 ident: CR24 article-title: Kinetics of acute hepatitis B virus infection in humans publication-title: J. Exp. Med. doi: 10.1084/jem.193.7.847 – volume: 188 start-page: 341 year: 1998 end-page: 350 ident: CR113 article-title: Immune pathogenesis of hepatocellular carcinoma publication-title: J. Exp. Med. doi: 10.1084/jem.188.2.341 – volume: 92 start-page: e02007 year: 2018 end-page: e02017 ident: CR13 article-title: Integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles publication-title: J. Virol. doi: 10.1128/JVI.02007-17 – volume: 302 start-page: 869 year: 1973 end-page: 873 ident: CR42 article-title: Antibody to hepatitis-B-virus core in man publication-title: Lancet doi: 10.1016/S0140-6736(73)92004-7 – volume: 64 start-page: 3326 year: 2004 end-page: 3333 ident: CR116 article-title: Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-03-3817 – volume: 99 start-page: 13717 year: 2002 end-page: 13722 ident: CR105 article-title: Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.172521999 – volume: 31 start-page: 558 year: 2020 end-page: 568 ident: CR133 article-title: Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019 publication-title: Ann. Oncol. doi: 10.1016/j.annonc.2020.02.012 – volume: 70 start-page: 105 year: 2012 end-page: 168 ident: CR143 article-title: The SLC10 carrier family: transport functions and molecular structure publication-title: Curr. Top. Membr. doi: 10.1016/B978-0-12-394316-3.00004-1 – volume: 14 start-page: 996 year: 2013 end-page: 1006 ident: CR149 article-title: Immune surveillance by the liver publication-title: Nat. Immunol. doi: 10.1038/ni.2691 – volume: 73 start-page: 52 year: 2020 end-page: 61 ident: CR83 article-title: Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.01.024 – volume: 30 start-page: 3067 year: 2000 end-page: 3078 ident: CR75 article-title: T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L – volume: 46 start-page: 1759 year: 2007 end-page: 1768 ident: CR139 article-title: Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans publication-title: Hepatology doi: 10.1002/hep.21896 – volume: 20 start-page: A80 year: 2002 end-page: A82 ident: CR92 article-title: The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection publication-title: Vaccine doi: 10.1016/S0264-410X(02)00392-4 – volume: 99 start-page: 51 year: 2016 end-page: 55 ident: CR87 article-title: Spatiotemporal dynamics of effector CD8 T cell responses within the liver publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.4MR0415-150R – volume: 73 start-page: 5767 year: 1999 end-page: 5776 ident: CR32 article-title: La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA publication-title: J. Virol. doi: 10.1128/JVI.73.7.5767-5776.1999 – volume: 179 start-page: 633 year: 2019 end-page: 640 ident: CR130 article-title: Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.8342 – volume: 11 start-page: 849 year: 2020 ident: CR77 article-title: Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.00849 – volume: 68 start-page: 893 year: 2018 end-page: 904 ident: CR112 article-title: Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection publication-title: Gut doi: 10.1136/gutjnl-2018-316644 – volume: 93 year: 2018 ident: CR115 article-title: Spatiotemporal differences in presentation of CD8 T cell epitopes during hepatitis B virus infection publication-title: J. Virol. doi: 10.1128/JVI.01457-18 – volume: 13 start-page: 277 year: 2016 end-page: 292 ident: CR150 article-title: Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2015.112 – volume: 180 start-page: 933 year: 1994 end-page: 943 ident: CR73 article-title: Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope publication-title: J. Exp. Med. doi: 10.1084/jem.180.3.933 – volume: 18 start-page: 135 year: 2016 end-page: 143 ident: CR6 article-title: HBV cure: why, how, when? publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2016.06.003 – volume: 22 start-page: 696 year: 1995 end-page: 699 ident: CR57 article-title: Histological grading and staging of chronic hepatitis publication-title: J. Hepatol. doi: 10.1016/0168-8278(95)80226-6 – volume: 128 start-page: 4573 year: 2018 end-page: 4587 ident: CR79 article-title: PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection publication-title: J. Clin. Invest. doi: 10.1172/JCI121957 – volume: 11 start-page: 1167 year: 2005 end-page: 1169 ident: CR124 article-title: Platelets mediate cytotoxic T lymphocyte-induced liver damage publication-title: Nat. Med. doi: 10.1038/nm1317 – volume: 36 start-page: 289 year: 2017 end-page: 303 ident: CR125 article-title: Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention publication-title: Cancer Metast Rev. doi: 10.1007/s10555-017-9675-z – volume: 369 start-page: 407 year: 1994 ident: 549_CR74 publication-title: Nature doi: 10.1038/369407a0 – volume: 11 start-page: 1225 year: 1999 ident: 549_CR49 publication-title: Int. Immunol. doi: 10.1093/intimm/11.8.1225 – volume: 128 start-page: 4588 year: 2018 ident: 549_CR78 publication-title: J. Clin. Invest. doi: 10.1172/JCI121960 – volume: 169 start-page: 5188 year: 2002 ident: 549_CR35 publication-title: J. Immunol. doi: 10.4049/jimmunol.169.9.5188 – volume: 78 start-page: 5707 year: 2004 ident: 549_CR110 publication-title: J. Virol. doi: 10.1128/JVI.78.11.5707-5719.2004 – volume: 74 start-page: 2255 year: 2000 ident: 549_CR33 publication-title: J. Virol. doi: 10.1128/JVI.74.5.2255-2264.2000 – volume: 161 start-page: 4520 year: 1998 ident: 549_CR55 publication-title: J. Immunol. doi: 10.4049/jimmunol.161.9.4520 – volume: 217 start-page: 2261 year: 2020 ident: 549_CR50 publication-title: J. Exp. Med. doi: 10.1084/jem.20191247 – volume: 2 start-page: 1104 year: 1996 ident: 549_CR8 publication-title: Nat. Med. doi: 10.1038/nm1096-1104 – volume: 16 start-page: 662 year: 2019 ident: 549_CR43 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-019-0196-9 – volume: 180 start-page: 933 year: 1994 ident: 549_CR73 publication-title: J. Exp. Med. doi: 10.1084/jem.180.3.933 – volume: 150 start-page: 194 year: 2016 ident: 549_CR98 publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.09.026 – volume: 70 start-page: 105 year: 2012 ident: 549_CR143 publication-title: Curr. Top. Membr. doi: 10.1016/B978-0-12-394316-3.00004-1 – volume: 96 start-page: 327 year: 1973 ident: 549_CR159 publication-title: Arch. Pathol. – volume: 36 start-page: 289 year: 2017 ident: 549_CR125 publication-title: Cancer Metast Rev. doi: 10.1007/s10555-017-9675-z – volume: 159 start-page: 1988 year: 2020 ident: 549_CR135 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.09.007 – volume: 22 start-page: 696 year: 1995 ident: 549_CR57 publication-title: J. Hepatol. doi: 10.1016/0168-8278(95)80226-6 – volume: 81 start-page: 100 year: 2007 ident: 549_CR104 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0306173 – volume: 214 start-page: 1567 year: 2017 ident: 549_CR100 publication-title: J. Exp. Med. doi: 10.1084/jem.20162115 – volume: 4 start-page: 25 year: 1996 ident: 549_CR45 publication-title: Immunity doi: 10.1016/S1074-7613(00)80295-2 – volume: 113 start-page: 1158 year: 2004 ident: 549_CR106 publication-title: J. Clin. Invest. doi: 10.1172/JCI200421087 – volume: 69 start-page: 6158 year: 1995 ident: 549_CR25 publication-title: J. Virol. doi: 10.1128/jvi.69.10.6158-6169.1995 – volume: 152 start-page: 3245 year: 1994 ident: 549_CR101 publication-title: J. Immunol. doi: 10.4049/jimmunol.152.7.3245 – volume: 11 start-page: 1167 year: 2005 ident: 549_CR124 publication-title: Nat. Med. doi: 10.1038/nm1317 – volume: 66 start-page: 177 year: 2012 ident: 549_CR39 publication-title: Annu. Rev. Microbiol. doi: 10.1146/annurev-micro-092611-150203 – volume: 76 start-page: 3570 year: 2002 ident: 549_CR97 publication-title: J. Virol. doi: 10.1128/JVI.76.7.3570-3574.2002 – volume: 234 start-page: 1398 year: 1986 ident: 549_CR84 publication-title: Science doi: 10.1126/science.3491425 – volume: 158 start-page: 5692 year: 1997 ident: 549_CR102 publication-title: J. Immunol. doi: 10.4049/jimmunol.158.12.5692 – volume: 104 start-page: 18187 year: 2007 ident: 549_CR36 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0708968104 – volume: 22 start-page: 737 year: 2015 ident: 549_CR160 publication-title: J. Viral Hepat. doi: 10.1111/jvh.12380 – volume: 93 year: 2018 ident: 549_CR115 publication-title: J. Virol. doi: 10.1128/JVI.01457-18 – volume: 7 year: 2011 ident: 549_CR103 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1002061 – volume: 154 start-page: 1778 year: 2018 ident: 549_CR29 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.01.034 – volume: 143 start-page: 637 year: 2012 ident: 549_CR54 publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.06.009 – volume: 284 start-page: 825 year: 1999 ident: 549_CR26 publication-title: Science doi: 10.1126/science.284.5415.825 – volume: 319 start-page: 1802 year: 2018 ident: 549_CR117 publication-title: JAMA doi: 10.1001/jama.2018.3795 – volume: 217 year: 2020 ident: 549_CR67 publication-title: J. Exp. Med. doi: 10.1084/jem.20200298 – volume: 62 start-page: S76 year: 2015 ident: 549_CR2 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.01.018 – volume: 30 start-page: 3067 year: 2000 ident: 549_CR75 publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L – volume: 12 start-page: 3215 year: 2020 ident: 549_CR134 publication-title: Cancers doi: 10.3390/cancers12113215 – volume: 193 start-page: 847 year: 2001 ident: 549_CR24 publication-title: J. Exp. Med. doi: 10.1084/jem.193.7.847 – volume: 9 start-page: 365 year: 2018 ident: 549_CR154 publication-title: Genes doi: 10.3390/genes9070365 – volume: 4 start-page: 545 year: 2019 ident: 549_CR4 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(19)30119-0 – volume: 91 start-page: 3764 year: 1994 ident: 549_CR44 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.9.3764 – volume: 5 start-page: a021444 year: 2015 ident: 549_CR118 publication-title: CSH Perspect. Med. – volume: 81 start-page: 4215 year: 2007 ident: 549_CR111 publication-title: J. Virol. doi: 10.1128/JVI.02844-06 – volume: 188 start-page: 341 year: 1998 ident: 549_CR113 publication-title: J. Exp. Med. doi: 10.1084/jem.188.2.341 – volume: 18 start-page: 827 year: 2019 ident: 549_CR7 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-019-0037-0 – volume: 89 start-page: 1269 year: 2009 ident: 549_CR23 publication-title: Physiol. Rev. doi: 10.1152/physrev.00027.2008 – volume: 179 start-page: 104816 year: 2020 ident: 549_CR53 publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2020.104816 – volume: 64 start-page: S84 year: 2016 ident: 549_CR119 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.021 – volume: 12 start-page: 309 year: 2015 ident: 549_CR81 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2015.25 – volume: 23 start-page: 874 year: 2016 ident: 549_CR127 publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-016-5520-9 – volume: 7 start-page: 1 year: 2020 ident: 549_CR145 publication-title: Ann. Rev. Virol. doi: 10.1146/annurev-virology-012420-024942 – volume: 115 start-page: 209 year: 2005 ident: 549_CR122 publication-title: J. Clin. Invest. doi: 10.1172/JCI24282 – volume: 5 year: 2016 ident: 549_CR151 publication-title: Clin. Transl Immunol. doi: 10.1038/cti.2016.53 – volume: 63 start-page: 1005 year: 2015 ident: 549_CR46 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.05.033 – volume: 64 start-page: S71 year: 2016 ident: 549_CR11 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.01.026 – volume: 9 year: 2013 ident: 549_CR47 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003490 – volume: 5 year: 2020 ident: 549_CR147 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.aba2351 – volume: 479 start-page: 672 year: 2015 ident: 549_CR10 publication-title: Virology doi: 10.1016/j.virol.2015.02.031 – volume: 49 start-page: S56 year: 2009 ident: 549_CR120 publication-title: Hepatology doi: 10.1002/hep.22962 – volume: 67 start-page: 7032 year: 1993 ident: 549_CR155 publication-title: J. Virol. doi: 10.1128/jvi.67.12.7032-7040.1993 – volume: 73 start-page: 474 year: 1999 ident: 549_CR31 publication-title: J. Virol. doi: 10.1128/JVI.73.1.474-481.1999 – volume: 8 year: 2018 ident: 549_CR128 publication-title: Sci. Rep. doi: 10.1038/s41598-018-23343-0 – volume: 73 start-page: 9710 year: 1999 ident: 549_CR15 publication-title: J. Virol. doi: 10.1128/JVI.73.12.9710-9717.1999 – volume: 52 start-page: 875 year: 2010 ident: 549_CR71 publication-title: Hepatology doi: 10.1002/hep.23778 – volume: 77 start-page: 68 year: 2003 ident: 549_CR41 publication-title: J. Virol. doi: 10.1128/JVI.77.1.68-76.2003 – volume: 23 start-page: 327 year: 2017 ident: 549_CR58 publication-title: Nat. Med. doi: 10.1038/nm.4275 – volume: 101 start-page: 14913 year: 2004 ident: 549_CR60 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0406282101 – volume: 20 start-page: A80 year: 2002 ident: 549_CR92 publication-title: Vaccine doi: 10.1016/S0264-410X(02)00392-4 – volume: 4 start-page: 1683 year: 2018 ident: 549_CR129 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2018.4154 – volume: 30 start-page: 9 year: 2018 ident: 549_CR38 publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2018.01.008 – volume: 574 start-page: 200 year: 2019 ident: 549_CR48 publication-title: Nature doi: 10.1038/s41586-019-1620-6 – volume: 1 year: 2012 ident: 549_CR142 publication-title: eLife doi: 10.7554/eLife.00049 – volume: 92 start-page: e02007 year: 2018 ident: 549_CR13 publication-title: J. Virol. doi: 10.1128/JVI.02007-17 – volume: 123 start-page: 3728 year: 2013 ident: 549_CR63 publication-title: J. Clin. Invest. doi: 10.1172/JCI68182 – volume: 12 start-page: 258 year: 2015 ident: 549_CR76 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2014.79 – volume: 99 start-page: 13717 year: 2002 ident: 549_CR105 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.172521999 – volume: 9 start-page: 75 year: 2017 ident: 549_CR153 publication-title: Viruses doi: 10.3390/v9040075 – volume: 191 start-page: 1269 year: 2000 ident: 549_CR108 publication-title: J. Exp. Med. doi: 10.1084/jem.191.8.1269 – volume: 32 start-page: 1117 year: 2000 ident: 549_CR40 publication-title: Hepatology doi: 10.1053/jhep.2000.19324 – volume: 151 start-page: 986 year: 2016 ident: 549_CR152 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.07.012 – volume: 98 start-page: 1017 year: 1990 ident: 549_CR156 publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90028-Y – volume: 73 start-page: 52 year: 2020 ident: 549_CR83 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.01.024 – volume: 44 start-page: 1182 year: 2006 ident: 549_CR91 publication-title: Hepatology doi: 10.1002/hep.21378 – volume: 9 start-page: 540 year: 2003 ident: 549_CR51 publication-title: Nat. Med. doi: 10.1038/nm866 – volume: 21 start-page: 950 year: 1995 ident: 549_CR141 publication-title: Hepatology doi: 10.1002/hep.1840210410 – volume: 123 start-page: 2604 year: 2013 ident: 549_CR52 publication-title: J. Clin. Invest. doi: 10.1172/JCI67008 – volume: 159 start-page: 652 year: 2020 ident: 549_CR68 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.04.019 – volume: 191 start-page: 1247 year: 2000 ident: 549_CR95 publication-title: J. Exp. Med. doi: 10.1084/jem.191.7.1247 – volume: 57 start-page: 985 year: 2013 ident: 549_CR140 publication-title: Hepatology doi: 10.1002/hep.26125 – volume: 101 start-page: 6669 year: 2004 ident: 549_CR28 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0401771101 – volume: 23 start-page: 1169 year: 2008 ident: 549_CR158 publication-title: J. Gastroen Hepatol. doi: 10.1111/j.1440-1746.2008.05348.x – volume: 109 start-page: E2165 year: 2012 ident: 549_CR18 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1209182109 – volume: 59 start-page: 1145 year: 1989 ident: 549_CR157 publication-title: Cell doi: 10.1016/0092-8674(89)90770-8 – volume: 92 start-page: 12398 year: 1995 ident: 549_CR30 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.92.26.12398 – volume: 68 start-page: 905 year: 2019 ident: 549_CR66 publication-title: Gut doi: 10.1136/gutjnl-2018-316641 – volume: 65 start-page: 658 year: 2015 ident: 549_CR70 publication-title: Gut doi: 10.1136/gutjnl-2014-308964 – volume: 35 start-page: 673 year: 2002 ident: 549_CR72 publication-title: Hepatology doi: 10.1053/jhep.2002.31867 – volume: 88 start-page: 4186 year: 1991 ident: 549_CR64 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.88.10.4186 – volume: 15 start-page: 85 year: 2020 ident: 549_CR5 publication-title: Clin. Liver Dis. doi: 10.1002/cld.904 – volume: 18 start-page: 135 year: 2016 ident: 549_CR6 publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2016.06.003 – volume: 66 start-page: 228 year: 2017 ident: 549_CR88 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.07.011 – volume: 23 start-page: 53 year: 2005 ident: 549_CR114 publication-title: Immunity doi: 10.1016/j.immuni.2005.05.005 – volume: 14 start-page: 1532 year: 2007 ident: 549_CR19 publication-title: Clin. Vaccine Immunol. doi: 10.1128/CVI.00298-07 – volume: 194 start-page: 1755 year: 2001 ident: 549_CR107 publication-title: J. Exp. Med. doi: 10.1084/jem.194.12.1755 – volume: 68 start-page: 893 year: 2018 ident: 549_CR112 publication-title: Gut doi: 10.1136/gutjnl-2018-316644 – volume: 151 start-page: 104585 year: 2019 ident: 549_CR131 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104585 – volume: 1 start-page: 98 year: 2004 ident: 549_CR123 publication-title: Nat. Clin. Pract. Gastr – volume: 5 start-page: 683 year: 1985 ident: 549_CR146 publication-title: Hepatology doi: 10.1002/hep.1840050427 – volume: 382 start-page: 1018 year: 2020 ident: 549_CR17 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1912035 – volume: 12 start-page: 269 year: 2015 ident: 549_CR86 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2014.78 – volume: 302 start-page: 869 year: 1973 ident: 549_CR42 publication-title: Lancet doi: 10.1016/S0140-6736(73)92004-7 – volume: 79 start-page: 3016 year: 2005 ident: 549_CR61 publication-title: J. Virol. doi: 10.1128/JVI.79.5.3016-3027.2005 – volume: 7 start-page: 16 year: 2018 ident: 549_CR80 publication-title: Emerg. Microbes Infec doi: 10.1038/s41426-018-0034-0 – volume: 72 start-page: 34 year: 2019 ident: 549_CR82 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.07.015 – volume: 4 start-page: 18035 year: 2018 ident: 549_CR3 publication-title: Nat. Rev. Dis. Primers doi: 10.1038/nrdp.2018.35 – volume: 79 start-page: 7269 year: 2005 ident: 549_CR37 publication-title: J. Virol. doi: 10.1128/JVI.79.11.7269-7272.2005 – volume: 226 start-page: 338 year: 1996 ident: 549_CR20 publication-title: Virology doi: 10.1006/viro.1996.0661 – volume: 128 start-page: 668 year: 2018 ident: 549_CR65 publication-title: J. Clin. Invest. doi: 10.1172/JCI92812 – volume: 64 start-page: 3326 year: 2004 ident: 549_CR116 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-03-3817 – volume: 55 start-page: 94 year: 2013 ident: 549_CR85 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2012.10.032 – volume: 5 start-page: a021477 year: 2015 ident: 549_CR94 publication-title: CSH Perspect. Med. – volume: 99 start-page: 51 year: 2016 ident: 549_CR87 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.4MR0415-150R – volume: 24 start-page: 1 year: 1996 ident: 549_CR138 publication-title: Hepatology – volume: 4 year: 2014 ident: 549_CR90 publication-title: Sci. Rep. doi: 10.1038/srep07341 – volume: 128 start-page: 4573 year: 2018 ident: 549_CR79 publication-title: J. Clin. Invest. doi: 10.1172/JCI121957 – volume: 14 start-page: 996 year: 2013 ident: 549_CR149 publication-title: Nat. Immunol. doi: 10.1038/ni.2691 – volume: 6 year: 2017 ident: 549_CR69 publication-title: eLife doi: 10.7554/eLife.26738 – volume: 5 start-page: a021469 year: 2015 ident: 549_CR59 publication-title: CSH Perspect. Med. – volume: 179 start-page: 633 year: 2019 ident: 549_CR130 publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.8342 – volume: 33 start-page: 965 year: 2018 ident: 549_CR126 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.03.002 – volume: 100 start-page: 11652 year: 2003 ident: 549_CR14 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1635109100 – volume: 73 start-page: 5767 year: 1999 ident: 549_CR32 publication-title: J. Virol. doi: 10.1128/JVI.73.7.5767-5776.1999 – volume: 3 start-page: 445 year: 1963 ident: 549_CR137 publication-title: Transfusion doi: 10.1111/j.1537-2995.1963.tb04673.x – volume: 67 start-page: 543 year: 2017 ident: 549_CR93 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.04.020 – volume: 64 start-page: 706 year: 2016 ident: 549_CR148 publication-title: Hepatology doi: 10.1002/hep.28650 – volume: 13 start-page: 277 year: 2016 ident: 549_CR150 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2015.112 – volume: 161 start-page: 486 year: 2015 ident: 549_CR89 publication-title: Cell doi: 10.1016/j.cell.2015.03.005 – volume: 20 start-page: 6 year: 2020 ident: 549_CR132 publication-title: BMC Gastroenterol. doi: 10.1186/s12876-020-1158-y – volume: 76 start-page: 8609 year: 2002 ident: 549_CR56 publication-title: J. Virol. doi: 10.1128/JVI.76.17.8609-8620.2002 – volume: 9 year: 2017 ident: 549_CR16 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aan0241 – volume: 9 start-page: 56 year: 2017 ident: 549_CR144 publication-title: Viruses doi: 10.3390/v9030056 – volume: 371 start-page: 838 year: 2008 ident: 549_CR121 publication-title: Lancet doi: 10.1016/S0140-6736(08)60383-9 – volume: 44 start-page: 1204 year: 2016 ident: 549_CR62 publication-title: Immunity doi: 10.1016/j.immuni.2016.04.008 – volume: 1 start-page: 23 year: 2006 ident: 549_CR1 publication-title: Annu. Rev. Pathol. Mech. Dis. doi: 10.1146/annurev.pathol.1.110304.100230 – volume: 11 start-page: 849 year: 2020 ident: 549_CR77 publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.00849 – volume: 36 start-page: 61 year: 2015 ident: 549_CR12 publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2015.06.016 – volume: 83 start-page: 9652 year: 2009 ident: 549_CR21 publication-title: J. Virol. doi: 10.1128/JVI.00867-09 – volume: 52 start-page: 1176 year: 1973 ident: 549_CR9 publication-title: J. Clin. Invest. doi: 10.1172/JCI107284 – volume: 93 start-page: 230 year: 1994 ident: 549_CR99 publication-title: J. Clin. Invest. doi: 10.1172/JCI116950 – volume: 195 start-page: 1089 year: 2002 ident: 549_CR109 publication-title: J. Exp. Med. doi: 10.1084/jem.20011723 – volume: 46 start-page: 1759 year: 2007 ident: 549_CR139 publication-title: Hepatology doi: 10.1002/hep.21896 – volume: 31 start-page: 558 year: 2020 ident: 549_CR133 publication-title: Ann. Oncol. doi: 10.1016/j.annonc.2020.02.012 – volume: 15 start-page: 1193 year: 2008 ident: 549_CR22 publication-title: Gene Ther. doi: 10.1038/gt.2008.60 – volume: 74 start-page: 4165 year: 2000 ident: 549_CR34 publication-title: J. Virol. doi: 10.1128/JVI.74.9.4165-4173.2000 – volume: 102 start-page: 9913 year: 2005 ident: 549_CR96 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0504273102 – volume: 40 start-page: 27 year: 2020 ident: 549_CR136 publication-title: Liver Int. doi: 10.1111/liv.14364 – volume: 101 start-page: 2129 year: 2004 ident: 549_CR27 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0308478100 |
| SSID | ssj0016174 |
| Score | 2.7209337 |
| SecondaryResourceType | review_article |
| Snippet | Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 19 |
| SubjectTerms | 631/250/2152/1566/1572 631/250/254 631/250/255/234/2513/1549 631/326/596/2553 631/326/596/2555 Adaptive immunity Biomedical and Life Sciences Biomedicine CD8 antigen CD8-Positive T-Lymphocytes Cell differentiation Chronic infection Cirrhosis Fibrosis Gene expression Genomes Hemodynamics Hepatitis Hepatitis B Hepatitis B surface antigen Hepatitis B virus - genetics Hepatitis B, Chronic - pathology Hepatocellular carcinoma Humans Immune clearance Immune response Immunology Infections Inflammation Liver cancer Liver cirrhosis Liver diseases Liver Neoplasms - etiology Lymphocytes Lymphocytes T Pathogenesis Review Article Viruses |
| Title | Immunobiology and pathogenesis of hepatitis B virus infection |
| URI | https://link.springer.com/article/10.1038/s41577-021-00549-4 https://www.ncbi.nlm.nih.gov/pubmed/34002067 https://www.proquest.com/docview/2616475247 https://www.proquest.com/docview/2528820970 |
| Volume | 22 |
| WOSCitedRecordID | wos000651329800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Nursing & Allied Health Database (Proquest) customDbUrl: eissn: 1474-1741 dateEnd: 20241214 omitProxy: false ssIdentifier: ssj0016174 issn: 1474-1733 databaseCode: 7RV dateStart: 20011001 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1da9RAcNBWiy9-VKun9Yjgmy5Nsp95ELGlRUGPo2i5t5Ds7dpCSerlrtB_35nN5ooU--LLwpKdZMnMzsfOF8D7iis0AtI5yzOXMsF1jWfOaealNyjN68qFvLWT73oyMbNZMY0Xbl0Mqxx4YmDU89bSHfkeavpKaJkL_fniD6OuUeRdjS007sMmtc0mOteztcFFqnvwKgstWKY5j0kzKTd7HQourRkFKJDWUjDxt2C6pW3e8pQGAXT05H-3_hQeR9Uz-dLTyjO455pteNg3o7zahq0f0c3-HD59o6yRoUBTUjXzhDoXt7-JMZ51SeuTU0eh2Euc7CeXZ4tVlwxhXc0L-HV0-PPgK4t9FphFZWjJrE4zJ01ua-msV1VqhPdou3qp50WtKPfUqkJRoXcpK68Lr_PaZtZ7Xem0KvgObDRt415BgiwLQbzKam6F9MqgOlbnXrocZ96LEWTDTy5tLEJOvTDOy-AM56bsEVMiYsqAmBJhPqxhLvoSHHeu3h2QUMbj2JU3GBjBu_VjPEjkHaka165wjczR2kgLnY7gZY_z9ee4ILVaIfTHgQhuXv7vvby-ey9v4FFOyRThQmcXNpaLlXsLD-wlIm8xRlI-PhkHgg6jwdEcZGPY3D-cTI_HFKU6vQbTqPrN |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3bTtRA9ITg9cULgi6ijok-6YR2Lp32gRhFCRuWjQ9oeBvb2RkhIS1udzH8FN_oOb0sMUTeePCx6Zx22nOfcwN4k8sEnYBowkXsI66kKZDnvOFBhxS1eZH7pm7t-8iMx-nhYfZ1CS76WhhKq-xlYiOoJ5WjM_JNtPQTZbRQ5sPpL05Toyi62o_QaMliz5__Rpet3hp-Rvy-FWLny8H2Lu-mCnCHqn_GnYlir1PhCu1dSPIoVSGgpxa0mWRFQpWWLskSamuudR5MFowoXOxCMLmJcmq-hCL_lpJCEhel24uUEnIVmii2MorHRsquSCeS6WaNitIYTgkRZCVlXP2tCK9Yt1cis43C23n4v_2qR_CgM63Zx5YXHsOSL1fgTjts83wF7u53aQRPYGtIVTF9AyqWlxNGk5mrnyT4j2tWBXbkKdV8hhef2NnxdF6zPm2tXIVvN_IZa7BcVqV_BgxFMoKEJC6kUzokKZqbhQjaC7wKQQ0g7pFqXddknWZ9nNgm2C9T2xKCRUKwDSFYhHm3gDltW4xcu3qjR7rtxE1tLzE-gNeL2ygoKPqTl76a4xot0JuKMhMN4GlLY4vXSUVuQ4LQ73uiu3z4v_eyfv1eXsG93YP9kR0Nx3vP4b6gwpHm8GoDlmfTuX8Bt90ZInL6smEjBj9umhj_AGcxUis |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD6aOpj2wmDAKAwwEjyB1cTX5GGaNraKaqOqEKC9mcS1YRJKRtMO7a_x63acSyc0sbc98GjFTuz487n43ABeZ1yhEhBNKYtdRAXXOZ45p6mXPkFunmeujlv7eqzH4-TkJJ2swJ8uFia4VXY0sSbU09KGO_IBSvpKaMmEHvjWLWJyMNw9-0VDBalgae3KaTQQOXIXv1F9q3ZGB7jXbxgbHn5-_4G2FQaoRTFgTq2OYicTZnPprFdZlAjvUWvzUk_TXIWoS6tSFVKcS5l5nXrNchtb73WmoywkYkLyv6o5rrcHq_uH48mnpQ1DNTmgY6EFjTXnbchOxJNBhWxTaxrcI4LMlFLxN1u8Jutes9PW7G-48T__uPtwrxW6yV5zSh7Aiis24W5ThvNiE9Y-tg4GD2FnFOJlutRUJCumJNRsLr8HlnBakdKTHy44oc-xsU_OT2eLinQObcUj-HIry3gMvaIs3BMgSKxxiFdxzq2QXiUoiObMS8ew5b3oQ9xtsLFt-vVQBeSnqd0AeGIaUBgEhalBYXDM2-WYsyb5yI29tzsAmJYQVeZq9_vwavkYSUiwC2WFKxfYRzLUs6JUR33YavC2_BwXQaFQOPpdB8Crl_97Lk9vnstLWEMMmuPR-OgZrLMQUVLfam1Dbz5buOdwx57jPs5etGeKwLfbRuMldUdciQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunobiology+and+pathogenesis+of+hepatitis+B+virus+infection&rft.jtitle=Nature+reviews.+Immunology&rft.au=Iannacone+Matteo&rft.au=Guidotti%2C+Luca+G&rft.date=2022-01-01&rft.pub=Nature+Publishing+Group&rft.issn=1474-1733&rft.eissn=1474-1741&rft.volume=22&rft.issue=1&rft.spage=19&rft.epage=32&rft_id=info:doi/10.1038%2Fs41577-021-00549-4&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1474-1733&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1474-1733&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1474-1733&client=summon |